Biochemistry, Genetics and Molecular Biology
Methylation
76%
DNA Methylation
71%
P53
64%
Loss of Heterozygosity
59%
Promoter Region
59%
Allele
54%
Genetics
45%
Allelic Imbalance
39%
Smoking
32%
Epigenetics
32%
Tumor Suppressor Gene
29%
Carcinogenesis
28%
Genome-Wide Association Study
26%
Real-Time Polymerase Chain Reaction
26%
Gene Mutation
24%
P16
22%
Genotyping
21%
Genome Instability
21%
Cytoglobin
21%
Single-Nucleotide Polymorphism
19%
Microsatellite Instability
19%
Microsatellite DNA
17%
Exon
16%
Pyrosequencing
16%
DNA Mismatch Repair
16%
Wart Virus
15%
Microarrays
15%
Human Papillomavirus Type 16
15%
Genetic Divergence
14%
Transcription Factors
14%
Tumor Progression
14%
Codon
13%
Cancer Cell
13%
Chromosome Instability
12%
Protein P53
12%
Messenger RNA
12%
Cancer Epigenetics
11%
Case-Control Study
11%
Ploidy
11%
Genetic Variation
10%
Chromosome Regions
10%
MicroRNA
10%
Population Genetics
10%
DNA Methyltransferase
10%
Long Non-Coding RNA
10%
FHIT
10%
P73
10%
Liquid
10%
Transcriptomics
10%
Microsatellite Marker
10%
Keyphrases
Lung Cancer
74%
Non-small Cell Lung Cancer (NSCLC)
69%
Loss of Heterozygosity
40%
Tumor Suppressor Gene
33%
Lung Cancer Risk
28%
Allelic Imbalance
25%
Promoter Methylation
24%
Tumor
24%
Allelic Loss
24%
Genomic Instability
23%
Methylation
22%
Cytoglobin
22%
Bronchial Lavage
21%
Head-and-neck
19%
Non-coding RNA (ncRNA)
16%
Squamous Cell Carcinoma of Head
16%
Breast Cancer
16%
Early-stage Lung Cancer
14%
DNA Methylation (DNAm)
14%
TP53 mutation
14%
High Risk
13%
Single nucleotide Polymorphism
12%
In Cancer
12%
Early Detection
11%
High-risk Human Papillomavirus (HR-HPV)
11%
Overexpression
11%
Head-and-neck Cancer
11%
P16INK4a
11%
Von Hippel-Lindau Tumor Suppressor
10%
First-degree Relatives
10%
Cancer Epigenetics
10%
Globin
10%
5p15.33
10%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
10%
Quantitative PCR
10%
Polymorphism
10%
Tumor Suppressor
10%
Lung Cancer Cell Lines
10%
Never-smokers
9%
HPV16
9%
Odds Ratio
9%
E-cadherin
9%
HMLH1
9%
Lung Cancer Screening
8%
Pyrosequencing
8%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
8%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
8%
Microsatellite Instability-high (MSI-H)
8%
Smokers
8%
Chromosomal Region
8%
Medicine and Dentistry
Lung Cancer
100%
Biological Marker
39%
Neoplasm
35%
DNA Methylation
30%
Methylation
29%
Disease
27%
Cancer Risk
24%
Mouth Squamous Cell Carcinoma
23%
Malignant Neoplasm
22%
Diagnosis
21%
Wart Virus
21%
Promoter Region
21%
Non Small Cell Lung Cancer
20%
Tumor Suppressor Gene
17%
P16
16%
Cytoglobin
16%
Tracheobronchial Toilet
15%
Protein P53
15%
Small Cell Lung Cancer
12%
Oropharynx Squamous Cell Carcinoma
11%
Carcinogenesis
10%
Oral Cancer
10%
Von Hippel-Lindau Tumor Suppressor
10%
Pooled Analysis
10%
Genetic Variation
10%
Sodium Valproate
10%
Smoking
10%
Immunohistochemistry
10%
Gene Mutation
10%
Human Papillomavirus Type 16
9%
Head and Neck Cancer
9%
Sensitivity and Specificity
8%
Cancer
8%
Allele
8%
Tumor Progression
8%
Family History
7%
Squamous Cell Carcinoma
7%
Real-Time Polymerase Chain Reaction
7%
Lung Carcinogenesis
7%
down Regulation
7%
Odds Ratio
7%
Histone Deacetylase Inhibitor
6%
Meta-Analysis
6%
Lung Carcinoma
6%
Cytotechnology
6%
Neck
6%
Exon
6%
Cell Line
6%
Phosphotransferase
6%
Histone Deacetylase
6%
